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ABSTRACT 20 
Progressive adaptation to bile might render some lactobacilli able to withstand 21 
physiological bile salt concentrations. In this work, the adaptation to bile was evaluated on 22 
previously isolated dairy strains of Lactobacillus delbrueckii subsp. lactis 200 and L. 23 
delbrueckii subsp. lactis 200+, a strain derived thereof with stable bile-resistant phenotype. 24 
The adaptation to bile was obtained by comparing cytosolic proteomes of both strains grown 25 
in the presence or absence of bile. Proteomics were complemented with physiological studies 26 
on both strains focusing on glycolytic end-products, the ability to adhere to the human 27 
intestinal epithelial cell line HT29-MTX and survival to simulated gastrointestinal conditions. 28 
Protein pattern comparison of strains grown with and without bile allowed us to identify 9 29 
different proteins whose production was regulated by bile in both strains, and 17 proteins that 30 
showed differences in their levels between the parental and the bile resistant derivative. These 31 
included general stress response chaperones, proteins involved in transcription and 32 
translation, in peptidoglycan/exopolysaccharide biosynthesis, in the lipid and nucleotide 33 
metabolism and several glycolytic and pyruvate catabolism enzymes. Differences in the level 34 
of metabolic end products of the sugar catabolism were found between the strains 200 and 35 
200+. A decrease in the adhesion of both strains to the intestinal cell line was detected in the 36 
presence of bile. In simulated gastric and intestinal juices, a protective effect was exerted by 37 
milk improving the survival of both microorganisms. These results indicate that bile tolerance 38 
in L. delbrueckii subsp. lactis involves several mechanisms responding to the deleterious 39 
impact of bile salts on bacterial physiology.  40 
 41 
 42 
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1. Introduction 43 
Lactobacillus species such as Lactobacillus casei, Lactobacillus rhamnosus, 44 
Lactobacillus acidophilus, and Lactobacillus plantarum occur naturally in the human 45 
intestine and, for this reason, they are being preferentially isolated and characterized for the 46 
development of commercial cultures to be used as probiotics in foods intended for human 47 
consumption (Vizoso Pinto et al., 2006). Non-intestinal Lactobacillus delbrueckii strains are 48 
important organisms for food fermentation. In particular, they are essential to the dairy 49 
industry for the production of yoghurt (L. delbrueckii subsp. bulgaricus) and hard cheeses (L. 50 
delbrueckii subsp. lactis) (Giraffa et al., 1998). Several results have been reported concerning 51 
the ability of strains of this species to adhere to intestinal epithelial cells, their capacity to 52 
survive the transit through the gastrointestinal tract (GIT) and the occurrence in human faeces 53 
after oral consumption, all these properties being strain dependent. Tannock (2003) and Wall 54 
et al. (2007) reported that L. delbrueckii subsp. bulgaricus and lactis are rarely found among 55 
the human gut microbiota due to their low capacity to survive the harsh conditions found 56 
during the GIT transit. However, there is evidence from other authors that a substantial 57 
proportion of L. delbrueckii can survive the GIT transit (Elli et al., 2006; Lick et al., 2001; 58 
Marteau et al. 1997; Mater et al., 2005). Immunomodulating capacity after oral administration 59 
of intact cells or cells included in fermented products has been reported (Adolfsson et al., 60 
2004; Guarner et al., 2005; Perdigón et al., 2000; Vinderola et al., 2007). Even for 61 
microorganisms not surviving the GIT transit, the health benefits ascribed to starter cultures 62 
such as L. delbrueckii or Streptococcus thermophilus, would primarily come from providing a 63 
source of enzymes which are important for improving the digestion of nutrients in the gut, 64 
such as -galactosidase (Gilliland, 1998), or can be related to their high proteolytic capacity 65 
which releases functional bioactive peptides from milk proteins (Hebert et al., 2008; 66 
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Korhonen and Pihlanto 2006) or to cell-wall rests derived from digested cells (Tsuruta et al, 67 
2009).  68 
It has been shown that some Gram-positive bacteria can develop an adaptive response 69 
when subjected to moderate stress conditions. In a previous work we reported on the isolation 70 
of bile-resistant derivatives from non-intestinal lactobacilli (Burns et al., 2008). The process 71 
of acquisition of permanent resistance to bile conferred the capacity to grow under 72 
physiological bile salt concentrations, which might be a valuable and natural tool for 73 
increasing the survival of non-intestinal dairy lactobacilli in the GIT ecosystem, thus 74 
enhancing their probiotic potential. In depth proteomic and genomic characterization of bile-75 
stress response has been carried out in L.  plantarum (Bron et al., 2004; Bron et al., 2006), 76 
Lactobacillus reuteri (Lee et al., 2008 ; Whitehead et al., 2008) and L. acidophilus (Pfeiler et 77 
al., 2007). Moreover, proteomic studies have been performed on L. delbrueckii subsp. 78 
bulgaricus during its growth in MRS broth, or under stress conditions imposed by lactic acid 79 
(Lim et al., 2000), heat (Gouesbet et al., 2002) or spray-drying (Silva et al., 2005). 80 
Nevertheless, a proteomic approach for a better understanding of bile tolerance in L. 81 
delbrueckii has not been performed yet. Taking all these data into consideration, the aim of 82 
the present work was to study the bile tolerance phenomenon in  L. delbrueckii subsp. lactis 83 
200, a highly autoaggregative strain isolated from natural whey starters in Argentina, and its 84 
bile-resistant derivative strain L. delbrueckii subsp. lactis 200+, a strain showing stable bile-85 
resistant phenotype (Burns et al., 2008). The effect of bile on these two strains was evaluated 86 
by using four different approaches: i) Soluble proteome during progressive bile exposure, ii) 87 
levels of glycolytic end products, lactate and acetate, iii) adhesion to human intestinal cell 88 
lines during progressive bile exposure, and iv) survival in simulated GIT conditions. To the 89 
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best of our knowledge, this work constitutes the first proteomic analysis of the species L. 90 
delbrueckii under bile stress conditions.  91 
 92 
2. Materials and Methods 93 
2.1. Strains and culture conditions 94 
The strains used in this study were L. delbrueckii subsp. lactis 200 and its bile-95 
resistant derivative L. delbrueckii subsp. lactis 200+. The bile resistant derivative was 96 
obtained and preliminary characterized in a previous work (Burns et al., 2008). Strains were 97 
grown in MRS broth (BioKar Diagnostics, Beauvais, France) and incubated at 37ºC for 18 h. 98 
After centrifugation, bacteria were resuspended in MRS broth containing 20% (v/v) glycerol 99 
and kept at -80ºC until use. As standard procedure, the strains were grown overnight directly 100 
from the stocks in MRS broth (Difco, Detroit, Michigan, USA) and these cultures were 101 
employed to inoculate (2% v/v) fresh MRS broth (Difco) and then incubated for a variable 102 
period of time depending on the experiment. For bacterial counting, decimal serial dilutions 103 
were made in quarter-strength Ringer’s solution (Merck, Darmstadt, Germany) which were 104 
pour-plated on MRS- agar (Biokar) and incubated for 48 h at 37ºC.  105 
 106 
2.2. Growth kinetics in the presence of bile salts 107 
The ability to grow in the presence of different concentrations of bile salts was 108 
determined in order to obtain a subinhibitory concentration of bile for the parental strain 109 
allowing the growth of both the parental strain and its bile-resistant derivative. This 110 
concentration was used to obtain the cytosolic proteome of both microorganisms during 111 
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progressive bile exposure. Overnight cultures at stationary phase (18 h) of L. delbrueckii 112 
subsp. lactis 200 and its bile-resistant derivative 200+ were inoculated (2% v/v) into MRS 113 
broth containing 0%, 0.2% or 0.5% (w/v) bovine bile salts (Sigma Chemical Co., St. Louis, 114 
MO, USA) and incubated in a water bath at 37ºC. Cell growth was measured at 600 nm at 115 
different time intervals. Two independent cultures were made for each condition.  116 
 117 
2.3. Extraction of cell-free proteins for 2D electrophoresis 118 
In order to accomplish proteomic experiments, L. delbrueckii subsp. lactis 200 and 119 
200+ were grown at 37ºC in MRS without bile and in MRS in the presence of a subinhibitory 120 
concentration of bile (0.2%). Cells were harvested at mid-exponential phase. Cultures were 121 
centrifuged (8,000 g, 4°C, 10 min) and washed twice in 0.1 M Tris-HCl buffer pH 7.5. Pellets 122 
obtained from 50 ml cultures were resuspended in 5 ml of 1 M Tris-HCl buffer pH 7.5, and 123 
lysed using a Cell Disrupter (Constant Systems Ltd., Daventry, United Kingdom) at 2.05x10
8
 124 
Pa. Unbroken cells and cell debris were removed by centrifugation (4,500 g, 4°C, 15 min) and 125 
membrane vesicles were discarded by ultracentrifugation (50,000 g, 4°C, 20 min). The protein 126 
concentration was measured using the BCA protein assay kit (Pierce, Rockford, IL, USA) 127 
following the manufacturer’s instructions. 128 
 129 
2.4. 2D Electrophoresis conditions and proteins identification 130 
Lactobacillus proteins were analyzed by 2D electrophoresis as previously described 131 
(Anglade et al., 2000; Marceau et al., 2004). Firstly, nucleic acids were removed from the 132 
protein preparations (500 µg) by a single incubation step of 30 min at 37°C in the presence of 133 
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50 U Benzonase (Merck KGaA) and 10 mM MgCl2.6H2O. Proteins were then precipitated 134 
using a methanol-chloroform protocol (Wessel and Flugge, 1984), and solubilised in 40 µl of 135 
a mixture containing 6.5 M deionised urea, 2.17 M thiourea (GE HealthCare, Biosciences, 136 
Uppsala, Sweeden), 65 mM 3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate 137 
(CHAPS; Sigma), 100 mM dithiothreitol (DTT), and 25 mM Tris-HCl buffer pH 8.8 138 
(Amersham Biosciences, Buckinghamshire, United Kingdom). The volume was adjusted to 139 
380 µl with a solution containing 6.5 M deionised urea, 2.17 M thiourea, 65 mM CHAPS, 100 140 
mM DTT, 0.5% pH 4.0 to 7.0 carrier ampholytes (Bio-Rad Laboratories, Hercules, CA), and 141 
2 µg bromophenol blue. This solution was used to rehydrate 24-cm pH 4.0 to 7.0 linear 142 
immobilized pharmalyte gradient strips (GE HealthCare), which were subsequently focused at 143 
60,000 V x h in a IPGphor (GE HealthCare). Strips were then sequentially equilibrated in a 144 
buffer [1 M Tris-HCl pH 6.8, containing 6 M urea, 30% (v/v) glycerol, 1% (w/v) SDS 145 
(Merck)] supplemented with 0.83% (w/v) DTT in the first equilibration step (15 min) and 146 
with 7.5% (wt/vol) iodoacetamide in the second one (15 min). Proteins were resolved by 147 
SDS-PAGE using a final polyacrylamide concentration of 12.5 % (w/v), in an Ettan Dalt Six 148 
System (GE HealthCare) (constant current of 10 mA/gel, 4°C). Proteins were visualized with 149 
a Bio-Safe Coomassie (Bio-Rad) staining according to the manufacturer’s instructions. Spot 150 
detection and volume quantification were performed with ImageMaster Platinum software 151 
(version 5.00, GE Healthcare). At least three independent gels from three independent 152 
extractions, each one coming from a different replicate, were performed for each growth 153 
condition. The effect of bile salts on the production of proteins was statistically determined by 154 
analysis of variance (ANOVA) of the normalized spot volume using either the bile salt 155 
concentration as a factor with two categories, 0 and 0.2%,  and the type of strain with two 156 
categories, parental and derivative, (P < 0.05). This quantification of the variations in spot 157 
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intensity was named variation factor (VF) and was fixed at 1.8 based on the former statistical 158 
analysis. 159 
Individual spots were excised from 2D gels. Proteins were identified by peptide mass 160 
fingerprinting after trypsinolysis and MALDI-TOF-MS at the Proteomic Unit of Centro 161 
Nacional de Investigaciones Cardiovasculares (CNIC; Madrid, Spain). Protein identification 162 
was performed against the two genomes of L. delbrueckii subsp. bulgaricus available at the 163 
NCBI site. Annotations were made according to the cluster of orthologous genes (COG) functional 164 
groups. Enzyme Database BRENDA (http//www.brenda-enzymes.info) was used to identify the 165 
metabolic pathway of some of the proteins.  166 
 167 
2.5. Metabolic activity in buffered resting cells 168 
In order to detect possible changes that the adaptation to bile could have promoted in 169 
the catabolism of carbohydrates of the bile adapted L. delbrueckii subsp. lactis 200+ strain 170 
with respect to the parental strain, glucose consumption and organic acids formation were 171 
measured in buffered suspensions of resting cells (Ruas-Madiedo et al., 2005) which were 172 
carried out in three independent replicates. In short, parental strain and its bile resistant-173 
derivative were grown in MRS without bile until mid-exponential phase (OD600nm of about 174 
1.2) and cells were harvested by centrifugation (10,000 g, 15 min, 5ºC). Pellets were washed 175 
twice with 33 mM potassium phosphate buffer pH 7.0 to eliminate residual components of the 176 
culture medium. Cells were then resuspended in 10 ml of 33 mM potassium phosphate buffer 177 
pH 5.6 containing 25 mM glucose and were incubated with constant mild stirring at 37ºC for 178 
4 h. Finally, cells were removed by centrifugation and the supernatants were collected for 179 
HPLC analysis.  180 
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A HPLC chromatographic system composed of an Alliance 2690 module injector, a 181 
Photodiode Array PDA 996 detector, a 410 refractive index (RI) detector and the Empower 182 
software (Waters, Milford, MA, USA) was used. Sample separation (50 µl vol injection) was 183 
carried out in an ICSep ION-300 ion-exchange column (Transgenomic, San Jose, CA, USA) 184 
using 8.5 mN H2SO4 as mobile phase at 65ºC and with a flow rate of 0.4 ml/min.  The glucose 185 
was detected by using the RI detector and the organic acids by using the PDA detector set at 186 
210 nm. For quantification, the regression equations (R
2
 0.99) were calculated using 187 
different concentrations of the corresponding standards purchased from Sigma. Results were 188 
expressed as mM and the ratio lactic to acetic acids (L/A) was calculated. 189 
 190 
2.6. Adhesion assay to epithelial intestinal cell lines  191 
The adhesion capability of the strains 200 and 200+ during progressive bile salt 192 
exposure was assessed against the epithelial intestinal cell line HT29-MTX that is able to 193 
constitutively produce mucin (Lesuffleur et al., 1993) and was kindly supplied by Dr. T. 194 
Lesuffleur (INSERM U843 Paris, France). The cell line was maintained in DMEM medium 195 
supplemented with 10% (v/v) heat-inactivated foetal bovine serum and a mixture of 196 
antibiotics to give a final concentration of 50 IU/ml penicillin, 50 µg/ml streptomycin, 50 197 
μg/ml gentamicin and 1.25 µg/ml amphotericin B. All media and reagents were purchased 198 
from Sigma and incubations took place at 37ºC, 5% CO2 in a SL Waterjacked CO2 Incubator 199 
(Sheldon Mfg. Inc., Cornelius, Oregon, USA). Culture media were changed every two days 200 
and the cell lines were weekly trypsinised with a trypsin-EDTA solution (0.25% trypsin, 201 
0.02% EDTA) (Sigma) following standard procedures. For experiments, 1 x 10
5 
cells/ml were 202 
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seed in 24-well plates and incubated to confluence for 13 ± 1 day. The cell line was used 203 
between passes 26 and 28.  204 
Bacterial suspensions were obtained from cultures in stationary phase (24 h) of the 205 
parental strain and its bile-resistant derivative in MRS with different concentrations of bile 206 
salts. The bile-resistant derivative was grown in MRS with 0%, 0.3% and 0.5% (w/v) bovine 207 
bile, whereas the parental strain was grown with 0%, 0.1% and 0.2% (w/v). These different 208 
concentrations of bile for parental and derivative strains were chosen looking for bile 209 
concentrations with a similar inhibitory capacity for both strains, as deduced from the relative 210 
decreases on growth rates. Bacteria were harvested from cultures by centrifugation (8,000 g, 211 
10 min, 5ºC), washed twice with PBS and resuspended in DMEM without antibiotics at a 212 
concentration of about 1 x 10
8
 CFU/ml. HT29-MTX monolayers were washed twice with 213 
Dubelco’s PBS buffer (Sigma) to remove the antibiotics and then bacterial suspensions were 214 
added in a ratio of epithelial cells/bacteria of 1:10. Plates were incubated for 1 h at 37°C, 5% 215 
CO2 in a Heracell  240 incubator (Thermo Electron LDD GmbH, Langenselbold, Germany). 216 
After the incubation period, supernatant was removed and wells were washed three times with 217 
Dubelco’s PBS buffer to remove the non-attached bacteria. Finally, the monolayers were 218 
trypsinised and counts to determine the number of adhered bacteria were performed in MRS-219 
agar. Results were expressed as the percentage of bacteria adhered with respect to the amount 220 
of bacteria added. 221 
 222 
2.7. Survival to simulated GIT digestion 223 
 The survival potential of the parental strain 200 and its bile resistant derivative 200+ to 224 
the passage through the GIT was studied by an in vitro model that has been modified from 225 
 11 
those previously described (Fernández et al., 2003; Zárate et al., 2000). The following 226 
components were used: (i) simulated gastric juice containing 125 mM NaCl, 7 mM KCl, 45 227 
mM NaHCO3 and 3 g/l pepsin (Sigma) pH 2.0 adjusted with HCl, (ii) simulated duodenal 228 
juice containing 1% (w/v) bovine bile (Sigma) pH 8.0 adjusted with 10 N NaOH, and (iii) 229 
simulated ileal juice containing 0.3% (w/v) bovine bile, 0.1% (w/v) pancreatin (Sigma) pH 230 
8.0 adjusted with 10 N NaOH. To simulate the GIT transit conditions, 10 ml of cultures 231 
(parental and bile-resistant derivative) grown in MRS for 24 h were harvested by 232 
centrifugation (10,000 g, 15 min, 5ºC). Pellets were washed twice with physiological salt 233 
solution (0.85% w/v NaCl) and cells were resuspended in 1 ml of the same saline solution. 234 
For each strain, 100 μl of the concentrated suspensions were centrifuged and resuspended 235 
either in 1 ml of simulated gastric juice or in 1 ml of gastric juice containing 20% (w/v) of 236 
skimmed milk. Bacterial suspensions were then incubated for 90 min at 37ºC with mild 237 
stirring (200 rpm). Afterwards, cells were harvested (10,000 g, 10 min), resuspended in the 238 
duodenal juice and incubated for 10 min at 37ºC in an anaerobic chamber (Mac 500, Don 239 
Whitley Scientific, West Yorkshire, UK) under a 10% H2, 10% CO2, and 80% N2 atmosphere. 240 
After this step, cells were again centrifuged, resuspended in the simulated ileal juice and 241 
incubated for 90 min at 37ºC in anaerobic conditions. Viable counts were obtained from the 242 
initial cultures and after simulation of each condition tested.  243 
 244 
2.8. Statistical analysis 245 
 Data were statistically analysed by means of one-way ANOVA tests using the SPSS 246 
11.0 software for Windows (SPSS Inc., Chicago IL.). For glucose consumption and organic 247 
acids formation by resting cells as well as for the survival to GIT and adhesion experiments, 248 
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independent ANOVA tests were performed employing the strain as factor, with two 249 
categories: parental and derivative. For adhesion results within each strain, independent 250 
ANOVA tests were performed using the bile salt concentration as factor. The differences 251 
between the three concentrations of bile salt tested within each strain were assessed by the 252 
mean comparison analysis LSD (least-significant difference, P < 0.05).  253 
 254 
3. Results 255 
3.1. Growth kinetics in the presence of physiological bile salt concentrations 256 
Figure 1 shows the growth of L. delbrueckii subsp. lactis 200 and its bile-resistant 257 
derivative L. delbrueckii subsp. lactis 200+ in the presence of different bile salt 258 
concentrations. The growth of both strains was strongly inhibited in the presence of 0.5% bile 259 
salts. Thus, a concentration of 0.2% (w/v) bile salts was chosen for further studies since it 260 
allowed a moderate growth of the parental strain and a more evident growth of the bile 261 
resistant derivative. Samples for proteomic studies were taken when the different cultures 262 
reached OD at 600 nm of 0.6. The time necessary to reach this OD varied between 2 and 10 h 263 
depending on the strain and the presence or absence of bile.  264 
 265 
3.2. Proteomic study of the adaptation to bile of strains 200 and 200+.  266 
We used a proteomic approach to characterize the adaptation to bile salts in strains 200 267 
and 200+. Our study focused on the cytosolic proteins in a pI range of 4.0 to 7.0. In these 268 
conditions the estimated coverage of the theoretical proteome of L. delbrueckii subsp. lactis 269 
was 52.1%, as extrapolated from the in silico proteomic data obtained from the two L. 270 
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delbrueckii subsp. bulgaricus genomes available at NCBI (data not shown) 271 
(http://www.ncbi.nlm.nih.gov/sites/genome). The comparison of proteomes from strain 200 272 
and strain 200+ in the absence of bile allowed us to identify constitutive changes leading to a 273 
stable bile-resistance phenotype in the strain 200+.  274 
Figure 2 shows 2D gels of proteins from cell-free extracts of strain 200 and its bile-275 
resistant derivative 200+, grown in the presence and absence of bile salts. 52 spots showed 276 
statistical differences in their production and they were identified. For further analysis, we 277 
focused only on spots which were considered to be up- or down- regulated when their 278 
variation factor (VF) was greater than 1.8 or lower than 0.55, respectively. According to this 279 
arbitrary criterion, the production of 35 proteins was modified by bile (Table 1). 280 
With regard to the transient response, Strains 200 and 200+ displayed 9 proteins that 281 
were up- or down- regulated by the presence of bile salts in both strains. The production of 282 
three enzymes of the glycolitic pathway was affected (Table 1; Figure 3); in both strains 283 
phosphoglycerate mutase (Figure 2; spot 393) and glyceraldehyde-3P-dehydrogenase (Figure 284 
2: spot 266) which successive bioactivity catalyses the interconversion of glyceraldehyde-3-285 
phophate to glyceraldehyde-1, 3-bisphophate were overproduced, whereas fructose-286 
biphosphate aldolase (Figure 2: spot 410) was under-produced. Apart from carbohydrate 287 
metabolism, other proteins involved in different functional categories such as transcription 288 
and translation,  lipids metabolism, and peptidoglycan and EPS biosynthesis changed their 289 
production levels in both microorganisms following bile salt exposure (Table 1; Figure 2), as 290 
it is the case of for example the expression of the protein EF-Tu, that was found to be down-291 
regulated as a response to in the presence of bile salts (Table 1; Figure 2: spot 215). Finally, it 292 
is worth mentioning the changes in the expression of proteins involved in general stress 293 
response. In our study, chaperones HtpO and GroES (Figure 2: spots 190 and 478, 294 
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respectively), as well as protease subunit of ATP dependent Clp protease (Figure 2: spot 427), 295 
were highly overproduced in the presence of response to bile salts, both in the parental and in 296 
the bile resistant derivative.  297 
The production of 17 proteins was significantly and permanently modified after the 298 
adaptation process, represented by in the bile resistant strain 200+. Two enzymes of the sugar 299 
catabolism were clearly over-produced in the bile resistant derivative: pyruvate kinase and 300 
phosphoglycerate mutase (Table 1; Figure 2: spots 84 and 393, respectively). Another enzyme 301 
of the pyruvate metabolism, the pyruvate oxidase (Figure 2: spot 79), was down-regulated 302 
(Table 1). Acquisition of permanent bile salt resistance Bile adaptation also promoted a 303 
pronounced up-regulation of glycosyltransferase, as well as of glycerol-3-phosphate 304 
dehydrogenase. Both enzymes may have an impact on the surface properties of the bile 305 
resistant adapted strain. The adaptation process bile promoted in the strain 200+ the down-306 
regulation of the chaperone HtpO, and the up-regulation of the protease and ATPase subunits 307 
of ATP dependent Clp protease (Figure 2: spots 228 and  427).   308 
A schematic representation of the proteins affected by the bile salts response and 309 
adaptation is shown in Fig. 4. Four categories were considered: energy metabolism, stress 310 
response, lipid metabolism and cell-envelope. 311 
 312 
3.3 Acquisition of stable bile resistant phenotype Bile adaptation modifies glycolytic flux 313 
Bile induced notable changes in several enzymatic activities involved in the central 314 
metabolism. This prompted us to measure the production of end-metabolites of the glycolytic 315 
pathway. HPLC analysis of the cell-free supernatants from resting cells incubated in a glucose 316 
containing buffer showed higher glucose consumption and more lactic acid formation in the 317 
bile resistant adapted strain 200+, whereas the acetic acid production was reduced (Table 2). 318 
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Therefore, the ratio lactic acid/acetic acid was significantly increased as a consequence of the 319 
acquired bile salt resistance.  320 
 321 
3.4. Bile salts affect adhesion capacity  322 
Bile salts induced changes in the production of some enzymes related to the cell 323 
envelope structure, so we hypothesized that bile may be influencing the surface properties of 324 
the cells. Therefore, we compared the adhesion to the intestinal cell line HT29-MTX of the 325 
strains 200 and 200+ at different bile concentrations. Parental and adapted bile resistant 326 
strains displayed a high adhesion capacity to the intestinal cell line HT29-MTX although this 327 
ability decreased in the strain adapted resistant to bile with respect to the parental 328 
microorganism. Notably, a significant decrease of cell adhesion capacity occurred when both 329 
parental and adapted bile resistant derivative strains were previously grown in the presence of 330 
bile salts (Figure 5).  331 
 332 
3.5. Survival to simulated GIT conditions. 333 
Finally, we tested whether the survival of both strains to simulated GIT conditions was 334 
affected. The influence of milk on this process was also investigated. When L. delbrueckii 335 
subsp. lactis 200 and 200+ were submitted to in vitro simulated GIT digestion, their viability 336 
decreased by about 5-6 log units, with some cells remaining still viable at the end of the 337 
sequential passage through the different solutions (Figure 6). No significant differences 338 
between either strain were found at the end of the process, although significantly higher 339 
viability of the parental strain was found after the gastric juice challenge. The presence of 340 
20% (v/v) milk improved the survival of both microorganisms through the simulated GIT and 341 
no differences between the strains 200 and 200+ were found.  342 
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 343 
4. Discussion 344 
In vitro data on bile resistance, adhesion and survival to simulated GIT conditions are 345 
performance indicators for probiotic strains intended to be used in human foods. Bile salts are 346 
able to disrupt the lipid bilayer structure of cellular membranes in Gram positive bacteria, 347 
which confers upon them a strong antimicrobial activity. Microorganisms surviving bile 348 
should undergo transient or permanent changes allowing them to overcome the deleterious 349 
action of these compounds. In the present study proteins involved in the adaptation of L. 350 
delbrueckii subsp. lactis to bile have been identified. Proteomics were complemented with 351 
physiological studies focusing on glycolytic end-products, the ability to adhere to the 352 
epithelial cell line HT29-MTX and the survival to simulated GIT conditions. The main results 353 
obtained are discussed next. 354 
 355 
4.1 Impact of transient response and adaptation and acquisition of stable bile resistant 356 
phenotype on the sugar metabolism  357 
Changes occurred in the production of enzymes from the glycolysis and pyruvate 358 
metabolism in L. delbrueckii subsp. lactis as a response to bile suggest an activation of the 359 
central glycolysis pathway favouring the formation of lactate, as indicated before for L. 360 
acidophilus in transcriptomic analyses (Pfeiler et al., 2007). As a direct consequence, ATP 361 
production and NAD
+
 regeneration may increase, which may provide the cells with enough 362 
energy for facing the higher energy consumption and the stress imposed by the adaptation to 363 
bile salts. Lee et al. (2008) recently showed the up-regulation in L. reuteri of five stress-364 
related proteins involved in sugar metabolism, which was consistent with similar findings 365 
found in Enterococcus faecalis by Giard et al. (2001). Among other enzymes, Lee et al. 366 
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(2008) observed a bile salt-associated up-regulation of mannitol-1-phosphate dehydrogenase, 367 
which catalyzes the conversion of fructose-phosphate to manitol-phosphate, favouring the 368 
generation of the electron acceptor NAD+ as observed in our study. 369 
The analysis of the production of end metabolic products from the carbohydrate 370 
catabolism (lactate and acetate) by the strain 200 and its bile resistant derivative 200+ showed 371 
an enhanced glucose consumption, and lactic acid formation to the detriment of acetic acid. 372 
This supported the hypothesis of global activation of the glycolytic pathway as a consequence 373 
of bile adaptation in L. delbrueckii subsp. lactis. Several authors have previously reported an 374 
activation of the glycolytic pathway in lactic acid bacteria and bifidobacteria, with enhanced 375 
production of energy rich intermediates under bile and acid stress conditions (Lee et al., 2008; 376 
Len et al., 2004a; Len et al., 2004b; Sánchez et al., 2005; Wilkins et al., 2001). 377 
 378 
4.2 Bile and general stress response 379 
Presence of bile salts induced the production of the chaperones GroES, HtpO and the 380 
protease subunit of ATP-dependent Clp protease in both strains, as well as the under-381 
production of HtpO and the over-production of two subunits of the ATP-dependent Clp 382 
protease. Van de Guchte et al. (2006) reported the presence in the L. bulgaricus genome of a 383 
few of the genes that are known to be involved in resistance to several stresses in other 384 
bacteria. A general response to stressful factors, such as bile or acid, has been previously 385 
demonstrated in other lactic acid bacteria including E. faecalis, Streptococcus mutants, L. 386 
reuteri, L. plantarum and L. acidophilus (Bron et al., 2006; Giard et al., 2001; Lee et al., 387 
2008; Len et al., 2004b; Wilkins et al., 2001) and in bifidobacteria (Sánchez et al., 2005, 388 
2007a, 2007b, 2008; Margolles and Yokota 2009). 389 
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Stress proteins such as heat shock proteins (HSPs) play different key roles in living 390 
systems. Many HSPs act as chaperones by guiding conformational states for the correct 391 
folding, translocation and protein assembly (Horváth et. al., 2008), contributing also to the 392 
degradation of proteins damaged by stress (Streit et. al., 2008). In our study, two subunits 393 
from the Clp protease were over-produced in the presence of bile. Frees and Ingmer (1999) 394 
suggested that Clp proteolytic complexes are essential for survival under adverse conditions. 395 
Previous works indicated that Clp proteases were up-regulated by bile in L. acidophilus and L. 396 
reuteri (Pfeiler et al., 2007; Whitehead et al., 2008), supporting an important role for 397 
molecular chaperones in counteracting the deleterious effects of bile.  398 
 399 
4.3 Impact of bile on enzymes involved on the cell-envelope synthesis and on the surface 400 
characteristics of L. delbrueckii subsp. lactis 401 
Bile induced the over-expression of two proteins related with the physiology of the 402 
bacterial cell-envelope, glycosyltransferase and glycerol-3-phosphate dehydrogenase. 403 
Glycosyltransferases catalyze the transfer of a monosaccharide unit from an activated sugar 404 
phosphate to an acceptor molecule and they can be involved in peptidoglycan and 405 
exopolysaccharide biosynthesis. Glycerol-3-phosphate dehydrogenase participates in the 406 
glycerolipid and glycerophospholipid metabolism, which are important components of cell 407 
membranes. Bile salt and other environmental stresses have been found to promote changes in 408 
fatty acid cell composition and cellular surface properties in lactobacilli and bifidobacteria 409 
(Gomez-Zavaglia et al., 2002; Guerzoni et al., 2001; Ruiz et al., 2007; Taranto et al., 2003). 410 
In addition, it is known that bile induced the synthesis of biofilm and EPS and some related 411 
genes in enteric bacteria (Hung et al., 2006; Ruas-Madiedo et al., 2009).  412 
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In order to know if bile could affect some surface-linked properties of our strains, we 413 
complemented proteomic findings by performing adhesion assays of the two strains in 414 
absence or presence of bile salts. We found that the presence of bile salts promoted a global 415 
decrease of the adhesion capacity to the intestinal cell line HT29-MTX. Bile salts have 416 
previously been shown to decrease the adherence adhesion of Bifidobacterium to intestinal 417 
mucus (Gueimonde et al. 2005). It may be possible that one or several proteic adhesins 418 
become down-regulated under bile stress, thus resulting in a decrease of the adhesion of the 419 
bacteria tested. In fact, cell surface characteristics depend on a number of properties such as 420 
presence of adhesins, exopolysaccharides, hydrophobicity, and rigidness, among other 421 
parameters. 422 
 423 
4.4 Survival to simulated GIT conditions 424 
After sequential exposure to simulated GIT juices, a reduced percentage of our L. 425 
delbrueckii subsp. lactis strains remained viable and no remarkable differences in survival 426 
were found between parental and bile resistant strains at the end of the process. Viability 427 
losses were in accordance with those previously reported for other strains of the same species 428 
(Vinderola and Reinheimer 2003). Our results also indicated that decreases in viability due to 429 
GIT digestion can be attenuated if the strains are added to milk.  430 
Surviving the transit through the GIT is generally considered a key feature of 431 
probiotics in order to fulfil their health-promoting effects (WHO/FAO 2002). It has 432 
traditionally been considered that yoghurt starters do not survive the GIT, although recent 433 
studies seem to confirm the presence of some strains of S. thermophilus and/or L. delbrueckii 434 
subsp. bulgaricus in human and animal faeces after the intake of these microorganisms in 435 
probiotic preparations (Elli et al., 2006; Lick et al., 2001; Mater et al., 2005).  436 
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 437 
In short, it could be assumed that both L. delbrueckii subsp. lactis 200 and 200+ can 438 
survive GIT digestion if ingested within a food matrix. The cell response to bile salts, 439 
although revealing both cell-wall and membrane adaptations, did not contemplate the 440 
synthesis of bile salts catabolising enzymes. The exposure to bile during passage through the 441 
small intestine could promote physiological changes in L. delbrueckii subsp. lactis directed to 442 
overcome the deleterious impact of bile salts on bacterial physiology. In spite of this, the 443 
adaptation to bile in L. delbrueckii subsp. lactis did not promote any improvement of their 444 
survival to the GIT conditions and adhesion capacity to intestinal eukaryotic cell lines as 445 
occurs with other intestinal lactic acid bacteria, probably because of the non-intestinal origin 446 
of this species.  447 
 448 
Acknowledgements 449 
 This work was supported by the following funds in Argentina: Programación CAI+D 450 
2006 37-203 (Universidad Nacional del Litoral, Santa Fe, Argentina), Project PICT 2004 451 
Nº09 20358 and PICT Jóvenes 2005 Nº 32118 from the Agencia Nacional de Promoción 452 
Científica y Tecnológica (ANPCyT), and Project PIP 5321 from CONICET. The following 453 
Spanish funds are acknowledged: projects AGL2006-03336 and AGL2007-62736 from 454 
Ministry of Science and Innovation. Patricia Burns received a 6-month grant from the 455 
Agencia Española de Cooperación Internacional for a research stay at IPLA (CSIC).  Lorena 456 
Ruiz and Borja Sánchez were the recipients of a predoctoral I3P fellowship from CSIC and a 457 
postdoctoral Juan de la Cierva contract from Spanish Ministry of Science and Innovation, 458 
respectively. Spanish and Argentinian groups shared a joint collaboration project CSIC-459 
CONICET (reference 2005AR0047).  460 
 21 
References  461 
Adolfsson, O., Meydani, S.N., Russell, R.M., 2004. Yogurt and gut function. American 462 
Journal of Clinical Nutrition 80, 245-256. 463 
 464 
Anglade, P., Demey, E., Labas, V., Le Caer J.P., Chich J.F., 2000. Towards a proteomic 465 
map of Lactococcus lactis NCDO 763. Electrophoresis 21, 2546–2549. 466 
 467 
Bron, P.A., Marco, M., Hoffer, S.M., Van Mullekom, E., de Vos, W.M., Kleerebezem, M. 468 
2004. Genetic characterization of the bile salt response in Lactobacillus plantarum and 469 
analysis of responsive promoters in vitro and in situ in the gastrointestinal tract. Journal of 470 
Bacteriology 186. 7829-7835.  471 
 472 
Bron, P.A., Molenaar, D., Vos, W.M., Kleerebezem, M. 2006. DNA micro-array-based 473 
identification of bile-responsive genes in Lactobacillus plantarum. Journal of Applied 474 
Microbiology 100, 728-738.  475 
 476 
Burns, P., Vinderola, G., Binetti, A., Quiberoni, A., de los Reyes Gavilán, C.G., 477 
Reinheimer, J., 2008. Bile-resistent derivatives obtained from non-intestinal dairy 478 
lactobacilli. International Dairy Journal 18, 377-385. 479 
 480 
Elli, M., Callegari, M.L., Ferrari, S., Bessi, E., Cattivelli, D., Soldi, S., Morelli, L., Goupil 481 
Feuillerat, N., Antoine, J.M., 2006. Survival of yogurt bacteria in the human gut. Applied 482 
and Environmental Microbiology 72, 5113–5117. 483 
 484 
 22 
Fernández, M.F., Boris, S., Barbes, C., 2003. Probiotic properties of human lactobacilli 485 
strains to be used in the gastrointestinal tract. Journal of Applied Microbiology 94, 449-486 
455. 487 
 488 
Frees, D., Ingmer, H., 1999. ClpP participates in the degradation of misfolded protein in 489 
Lactococcus lactis. Molecular Microbiology 31, 79–87. 490 
 491 
Giard, J.C., Laplace, J.M., Rincé, A., Pichereau, V., Benachour, A., Leboeuf, C., Flahaut,  492 
S., Auffray, Y., Hartke, A., 2001. The stress proteome of Enterococcus faecalis. 493 
Electrophoresis 22, 2947–2954. 494 
 495 
Gilliland, S.E., 1998. Fermented milks and probiotics. In: Marth, E.H., Steel, J.L. (Eds.) 496 
Applied Dairy Microbiology. Marcel Dekker Inc, New York, USA, 195-212. 497 
 498 
Giraffa, G., De Vecchi, P., Rossetti, L., 1998. Note: Identification of Lactobacillus 499 
delbrueckii subspecies bulgaricus and subspecies lactis dairy isolates by amplified rDNA 500 
restriction analysis. Journal of Applied Microbiology 85, 918-924. 501 
 502 
Gómez-Zavaglia, A., Kociubinski, G., Pérez, P., Disalvo, E., de Antoni, G., 2002. Effect 503 
of bile on the lipid composition and surface properties of bifidobacteria. Journal of 504 
Applied Microbiology 93, 794-799.  505 
 506 
 23 
Gouesbet, G., Jan, G., Boyaval, P., 2002. Two-dimensional electrophoresis study of 507 
Lactobacillus delbrueckii subsp. bulgaricus thermotolerance. Applied and Environmental 508 
Microbiology 68(3), 1055-1063. 509 
 510 
Guarner, F., Perdigón, G., Corthier G., Salminen, S., Koletzko, B., Morelli, L., 2005. 511 
Should yoghurt cultures be considered probiotic? British Journal of Nutrition 93, 783-786. 512 
 513 
Gueimonde, M., Noriega, L.,  Margolles, A., de los Reyes-Gavilán, C.G., Salminen, S., 514 
2005. Ability of Bifidobacterium strains with acquired resistance to bile to adhere to 515 
human intestinal mucus. International Journal of Food Microbiology 101, 341– 346. 516 
 517 
Guerzoni, M.E., Lanciotti, R., Cocconcelli, P.S., 2001. Alteration in cellular fatty acid 518 
composition as a response to salt, acid, oxidative and thermal stresses in Lactobacillus 519 
helveticus. Microbiology 147, 2255-2264.  520 
 521 
Hebert, E.M., Mamone, G., Picariello, G., Raya, R.R., Savoy, G., Ferranti, P., Addeo, F. 522 
2008. Characterization of the pattern of alpha(s1)-and beta-casein breakdown and release 523 
of a bioactive peptide by a cell envelope proteinase from Lactobacillus delbrueckii subsp. 524 
lactis CRL 581. Applied and Environmental Microbiology 74, 3682-3689.  525 
 526 
 527 
Horváth, I., Multhoff, G., Sonnleitner, A., Vígh, L., 2008. Membrane-associated stress 528 
proteins: More than simply chaperones. Biochimica et Biophysica Acta 1778, 1653–1664. 529 
 530 
 24 
Hung, D.T., Zhu, J., Sturtevant, D., Mekalanos, J.J., 2006. Bile acids stimulate biofilm 531 
formation in Vibrio cholerae. Molecular Microbiology 59, 193-201.  532 
 533 
Korhonen, H., Pihlanto, A. 2006. Bioactive peptides: production and functionality. 534 
International Dairy Journal 16, 945-960.  535 
 536 
Lee, K., Lee, H.G., Choi, Y.J., 2008. Proteomic analysis of the effect of bile salts on the 537 
intestinal and probiotic bacterium Lactobacillus reuteri. Journal of Biotechnology 137, 538 
14–19. 539 
 540 
Len, M.C.L., Harty, D.W.S., Jacques, N.A., 2004a. Proteome analysis of Streptococcus 541 
mutans metabolic phenotype during acid tolerance. Microbiology-SGM 150, 1353-1366.  542 
 543 
Len, A.C.L., Harty, D.W.S., Jacques, N.A., 2004b. Stress-responsive proteins are 544 
upregulated in Streptococcus mutans during acid tolerance. Microbiology-SGM 150, 545 
1339-1351.  546 
 547 
Lesuffleur, T., Porchet, N., Aubert, J.P., Swallow, D., Gum, J.R., Kim, Y.S., Real, F.X., 548 
Zweibaum, A., 1993. Differential expression of the human mucin genes MUC1 to MUC5 549 
in relation to growth and differentiation of different mucus-secreting HT-29 cell 550 
subpopulations. Journal of Cell Science 106, 771-783.  551 
 552 
 25 
Lick, S., Drescher, K., Heller, K.J., 2001. Survival of Lactobacillus delbrueckii subsp. 553 
bulgaricus and Streptococcus thermophilus in the terminal ileum of fistulated Göttingen 554 
minipigs. Applied and Environmental Microbiology 67, 4137–4143. 555 
 556 
Lim, E.M., Ehrlich, S.D., Maguin, E., 2000. Identification of stress-inducible proteins in 557 
Lactobacillus delbrueckii subsp. bulgaricus. Electrophoresis 21, 2557-2561. 558 
 559 
Marceau, A., Zagorec, M., Chaillou, S., Méra, T., Champomier-Vergès M.C., 2004. 560 
Evidence for the involvement of at least six proteins in Lactobacillus sakei adaptation to 561 
cold temperatures and addition of NaCl. Applied and Environmental Microbiology 70, 562 
7260–7268. 563 
 564 
Marteau, P., Minekus, M., Havenaar, R., Huis In’t Veld, J.H.J. 1997. Survival of lactic 565 
acid bacteria in a dynamic model of the stomach and small intestine: validation and the 566 
effects of bile. Journal of Dairy Science 80, 1031-1037.  567 
 568 
Mater, D.D.G., Bretigny, L., Firmesse, O., Flores, M.J., Mogenet, A., Bresson, J.L., 569 
Corthier, G., 2005. Streptococcus thermophilus and Lactobacillus delbrueckii subsp 570 
bulgaricus survive gastrointestinal transit of healthy volunteers consuming yogurt. FEMS 571 
Microbiology Letters 250, 185–187. 572 
 573 
Perdigón, G., Medina, M., Vintiñi, E., Valdez, J.C., 2000. Intestinal pathway of 574 
internalisation of lactic acid bacteria and gut mucosal immunostimulation. International 575 
Journal of Immunopathology and Pharmacology 13(3), 141-150. 576 
 26 
 577 
Pfeiler, E.A., Azcarate-Peril, M.A., Klaenhammer, T.R., 2007. Characterization of a novel 578 
bile-inducible operon encoding a two-component regulatory system in Lactobacillus 579 
acidophilus. Journal of Bacteriology 189, 4192-4198. 580 
 581 
Ruas-Madiedo, P., Hernández-Barranco, A.M., Margolles, A., de los Reyes-Gavilán, 582 
C.G., 2005. A bile salt-resistant derivative of Bifidobacterium animalis has an altered 583 
fermentation pattern when grown on glucose and maltose. Applied and Environmental 584 
Microbiology 71, 6564-6570. 585 
 586 
Ruas-Madiedo, P., Gueimonde, M., Arigoni, F., de los Reyes-Gavilán, C.G., Margolles, 587 
A., 2009. Bile affects the synthesis of exopolysaccharides by Bifidobacterium animalis. 588 
Applied and Environmental Microbiology 75, 1204-1207.  589 
 590 
Ruiz, L., Sánchez, B., Ruas-Madiedo, P., de los Reyes-Gavilán, C.G., Margolles, A., 591 
2007. Cell envelope changes in Bifidobacterium animalis ssp. lactis as a response to bile. 592 
FEMS Microbiology Letters 274, 316-322.  593 
 594 
Sánchez, B., Champomier-Vergès, M.C., Anglade, P., Baraige, F., de los Reyes-Gavilán, 595 
C.G., Margolles, A., Zagorec, M., 2005. Proteomic Analysis of Global Changes in Protein 596 
Expression during Bile Salt Exposure of Bifidobacterium longum NCIMB 8809. Journal 597 
of Bacteriology 187, 5799–5808. 598 
 599 
 27 
Sánchez, B., Champomier-Vergés, M.C., Stuer-Lauridsen, B., Ruas-Madiedo, P., 600 
Anglade, P., Baraige, F., de los Reyes-Gavilán, C.G., Johansen, E., Zagorec, M., 601 
Margolles, A., 2007a. Adaptation and response of Bifidobacterium animalis subsp. lactis 602 
to bile: a proteomic and physiological approach. Applied and Environmental 603 
Microbiology 73, 6757-6767.  604 
 605 
Sánchez, B., Champomier-Vergés, M.C., Collado, M.C., Anglade, P., Garaige, F., Sanz, 606 
Y., de los Reyes-Gavilán, C.G., Margolles, A., Zagorec, M., 2007b. Low-pH adaptation 607 
and the acid tolerance response of Bifidobacterium longum biotype longum. Applied and 608 
Environmental Microbiology 73, 6450-6459.  609 
 610 
Sánchez, B., Ruíz, L., de los Reyes-Gavilán, C.G., Margolles, A., 2008. Proteomics of 611 
stress response in Bifidobacterium. Frontiers in Biosciences 13, 6905-6919.  612 
 613 
Silva, J., Carvalho, A.S., Ferreira, R., Vitorino, R., Amado, F., Domingues, P., Texeira, 614 
P., Gibbs, P.A., 2005. Effect of the pH of growth on the survival of Lactobacillus 615 
delbrueckii subsp. bulgaricus to stress conditions during spray-drying. Journal of Applied 616 
Microbiology 98, 775-782. 617 
 618 
Streit, F., Delettre, J., Corrieu, G., Béal, C., 2008. Acid adaptation of Lactobacillus 619 
delbrueckii subsp. bulgaricus induces physiological responses at membrane and cytosolic 620 
levels that improves cryotolerance. Journal of Applied Microbiology 105, 1071–1080. 621 
 622 
 28 
Tannock, G.W., 2003. The intestinal microflora. In Fuller, R., Perdigón, G., (Eds), Gut 623 
flora. Nutrition, immunity and health. Blackwell Press, Oxford, 1-23. 624 
 625 
Taranto, M.P., Fernández-Murga, M.L., Lorca, G., de Valdez, G.F., 2003. Bile salts and 626 
cholesterol induce changes in the lipid cell membrane of Lactobacillus reuteri. Journal of 627 
Applied Microbiology 95, 86-91.  628 
 629 
Tsuruta, T., Inoue, R., Tsukahara, T., Matsubara, N., Hamasaki, M., Ushida, K., 2009. A 630 
cell preparation of Enterococcus faecalis strain EC-12 stimulates the luminnal 631 
immunoglobulin A secretion in juvenile calves. Animal Science Journal 80, 206-211.  632 
 633 
Van de Guchte, M., Penaud, S., Grimaldi, C., Barbe, V., Bryson, K., Nicolas, P., Robert, 634 
C., Oztas, S., Mangenot, S., Couloux, A., Loux, V., Dervyn, R., Bossy, R., Bolotin, A., 635 
Batto, J.M., Walunas, T., Gibrat, J.F., Bessières, P., Weissenbach, J., Ehrlich, S.D., 636 
Maguin, E.,  2006. The complete genome sequence of Lactobacillus bulgaricus reveals 637 
extensive and ongoing reductive evolution. Proceedings of the National Academy of 638 
Sciences 103, 9274-9279.  639 
 640 
Vinderola G., Reinheimer J., 2003. Lactic acid starter and probiotic bacteria: a 641 
comparative ‘‘in vitro’ study of probiotic characteristics and biological barrier resistance. 642 
Food Research International 36, 895–904. 643 
 644 
Vinderola, G., Marcó, M.B., Guglielmotti, D.M., Perdigón, G., Giraffa, G., Reinheimer, 645 
J., Quiberoni, A., 2007. Phage-resistant mutants of Lactobacillus delbrueckii may have 646 
 29 
functional properties that differ from those of parent strains. International Journal of Food 647 
Microbiology 116, 96-102. 648 
 649 
Vizoso Pinto, M.G., Franz, F.M., Shillinger, U., Holzapfel, W.H., 2006. Lactobacillus 650 
spp. with in vitro probiotic properties from human faeces and traditional fermented 651 
products. International Journal of Food Microbiology 109, 205-214. 652 
 653 
Wall, R., Fitzgerald, G., Hussey, S., Ryan, T., Murphy, B., Ross, P., Stanton, C., 2007. 654 
Genomic diversity of cultivable Lactobacillus populations residing in the neonatal and 655 
adult gastrointestinal tract. FEMS Microbiology Ecology 59, 127-137. 656 
 657 
Wessel, D., Flugge, U.I., 1984. A method for the quantitative recovery of protein in 658 
dilute-solution in the presence of detergents and lipids. Analytical Biochemistry 138, 141-659 
143.  660 
Whitehead, K., Versalovic, J., Roos, S., Britton, R.A. 2008. Genomic and genetic 661 
characterization of the bile stress response of probiotic Lactobacillus reuteri ATCC 662 
55730. Applied and Environmental Microbiology 74, 1812-1819.  663 
 664 
WHO/FAO.  2002. Guidelines for the evaluation of probiotics in food. London, Ontario, 665 
Canada.http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/index.666 
htm. 667 
 668 
 30 
Wilkins, J.C., Homer, K.A., Beighton, D., 2001. Altered protein expression of 669 
Streptococcus oralis cultured at low pH revealed by two-dimensional gel electrophoresis. 670 
Applied and Environmental Microbiology 67, 3396-3405.  671 
 672 
Zárate, G., Perez-Chaia, A., González, S., Oliver, G., 2000. Viability and β-galactosidase 673 
activity of dairy propionibacteria subjected to digestion by artificial gastric and intestinal 674 
fluids. Journal of Food Protection 63(9), 1214-1221. 675 
 676 
 677 
FIGURE LEGENDS 678 
 679 
Figure 1 - Growth kinetics of L. delbrueckii subsp. lactis 200 and its bile-resistant derivative 680 
L. delbrueckii subsp. lactis 200+. Solid lines with white symbols represent the parental strain 681 
and dashed lines with black symbols the bile-resistant derivative. Growth in MRS broth with 682 
0% (squares), 0.2% (triangles) and 0.5% (circles) of bile salts. 683 
 684 
Figure 2 – 2D gels of cytoplasmatic extracts from mid-exponential phase cells of L. 685 
delbrueckii subsp. lactis 200 (a, and b) and L. delbrueckii subsp. lactis 200+ (c, and d) grown 686 
without (a, and c) and with (b, and d) bile salts. Spots identified by peptide mass 687 
fingerprinting are labelled and their identification is listed in Table 1.  688 
 689 
 31 
Figure 3 - Schematic representation of the homofermentative pathway and pyruvate 690 
metabolism in L. delbrueckii according to the KEGG database (http://www.genome.jp/kegg). 691 
Glk, glucokinase; Gpi, glucose-6-phosphate isomerise; Pfk, 6-phosphofructokinase; Fba, 692 
fructose-1,6-bisphosphate aldolase; Gap, glyceraldehyde-3-phosphate dehydrogenase; Tpi, 693 
triosephosphate isomerase; Pgk, phosphoglycerate kinase; Gpm, phosphoglycerate mutase; 694 
Eno, enolase; Pyk, pyruvate kinase; Ldh2, lactate dehydrogenase; Pox, pyruvate oxydase; Pta, 695 
Phosphate acetyltransferase; Ack, acetate kinase; Acp, acylphosphatase; Adh, alcohol-696 
acetaldehyde dehydrogenase. Enzymes whose production changed in response and/or 697 
adaptation are highlighted in grey.  698 
 699 
Figure 4 – Histogram representation of the number of proteins from L. delbrueckii subsp. 700 
lactis 200 and its bile resistant derivative L. delbrueckii subsp. lactis 200+ whose production 701 
changed by exposure to bile grouped in four categories: energy metabolism and translation 702 
(including the following functional COG categories: carbohydrate metabolism, nucleotide 703 
metabolism, and translation), stress response (corresponding with folding, sorting and 704 
degradation category of COG), lipid metabolism, and exopolysaccharide synthesis 705 
(corresponding with peptidoglycan biosynthesis category of COG). COG: Cluster of 706 
Orthologous Genes. 707 
 708 
Figure 5 - Adhesion of L. delbrueckii subsp. lactis 200 and its bile-resistant derivative L. 709 
delbrueckii subsp. lactis 200+ to the HT29-MTX intestinal cell line. (     ) MRS without bile; (    710 
) MRS + 0.1% or 03% bile for strains 200 and 200+, respectively; (    ) MRS + 0.2% or 0.5% 711 
bile for strains 200 and 200+, respectively.  712 
 32 
 713 
Figure 6 - Survival of L. delbrueckii subsp. lactis 200 and its bile-resistant derivative 200+ 714 
during simulated GIT transit in absence and presence of 20% skimmed milk. Bacterial counts 715 
were determined in each step. GJ: gastric juice, DJ; duodenal juice: IJ; ileal juice. *: parental 716 
and bile-resistant derivative are statistically different (p< 0.05). (     ) parental strain, (    ) bile-717 
resistant derivative strain  718 
 719 
 720 
 721 
 1 
Table 1. Proteins affected by bile salts exposure in L. delbrueckii subsp. lactis 200 and its bile resistant derivative L. delbrueckii subsp. lactis 200+. N = 3 for each growth condition. Bold face letters indicate 
proteins whose expression changed in the derivative in the absence of bile (S: stable bile resistance phenotype) and in both the parental and the derivative in the presence of bile (A: adaptation).  
           
Stable bile 
resistance  
Adaptation 
COG
a
 Spot
b
 Putative function
c
 pI
d
 MM
e
 Cv
f
 Mo
g
 Norm. V
h
 
200 
Norm. V
h 
200b 
Norm. V
h
 
200+ 
Norm. V
h
 
200+b 
VF
i 
200+/200 
VF
j
 
200b/200 
VF
k
 
200+b/200+ 
Carbohydrate 
metabolism 
266 Glyceraldehyde 3-phosphate dehydrogenase  (A) 5.51 36.7 15 176 1.500±0.880 4.750±0.250 1.250±0.060 3.500±0.630 0.83 3.17 2.80 
84 Pyruvate kinase (S) 5.22 63.1 48 512 0.100±0.100 0.150±0.060 0.430±0.050 0.280±0.050 4.30 1.50 0.65 
 410 Fructose-bisphosphate aldolase (A) 4.90 33.2 24 107 0.130±0.070 0.017±0.017 0.100±0.020 0.033±0.030 0.77 0.13 0.33 
 322 HPr kinase/phosphorylase 5.32 35.2 45 465 0.013±0.013 0.025±0.025 - - na 1.92 na 
 326 UTP-glucose-1-phosphate uridylyltransferase 6.42 33.9 26 256 0.005±0.005 0.010±0.010 - - na 2.00 na 
 123 Acetyl-CoA carboxylase, biotin carboxylase subunit 5.74 51.2 33 296 2.170±1.170 2.500±0.170 1.670±0.670 3.670±0.250 0.77 1.15 2.20 
 312 Phosphotransacetylase 5.05 35.6 38 301 0.110±0.020 0.250±0.030 0.110±0.010 0.190±0.010 1.00 2.27 1.73 
 79 Pyruvate oxidase (S) 4.96 67.7 30 263 0.200±0.003 0.310±0.030 0.100±0.100 0.380±0.150 0.50 1.55 3.80 
 281 D-lactate dehydrogenase 5.08 36.9 29 246 0.880±0.060 0.550±0.560 1.560±0.500 1.630±0.130 1.77 0.63 1.04 
 393 Phosphoglycerate mutase ( A, S) 5.24 26.1 47 204 0.033±0.025 0.210±0.050 0.120±0.090 0.260±0.060 3.64 6.36 2.17 
Lipid metabolism 332 Glycerol-3-phosphate dehydrogenase (S) 5.78 36.6 27 248 0.012±0.012 0.011±0.010 0.027±0.012 0.034±0.006 2.25 0.92 1.26 
 226 3-oxoacyl-(acyl-carrier-protein) synthase (A) 5.39 41.7 32 165 0.400±0.020 0.011±0.008 0.570±0.120 0.010±0.008 1.43 0.03 0.02 
 360 Enoyl-[acyl-carrier protein] reductase (NADH) (S) 5.23 27.1 29 228 0.180±0.140 - 0.440±0.040 - 2.44 na na 
Peptidoglycan and 
EPS biosynthesis  
261 Glycosyltransferase (S) 4.86 37.2 26 123 0.010±0.010 0.020±0.020 0.160±0.160 0.260±0.140 16 2.00 1.63 
Amino acid 
metabolism 
296 Branched-chain amino acid aminotransferase 5.15 38.0 26 89 0.025±0.025 0.100±0.090 - - na 4.00 na 
247 Predicted tRNA methyltransferase 5.20 42.4 35 214 0.090±0.040 0.038±0.006 0.060±0.010 0.037±0.003 0.66 0.42 0.62 
 438 Peptide methionine sulfoxide reductase 4.69 19.9 32 119 0.056±0.016 0.031±0.031 0.089±0.006 0.106±0.003 1.59 0.55 1.19 
Nucleotide 
metabolism 
459 Adenylyl-sulfate reductase (Thioredoxin) 4.28 11.8 26 118 0.210±0.050 0.100±0.100 - - na 0.48 na 
38 Adenosylcobalamin-dependent ribonucleoside-
triphosphate reductase (S) 
5.02 82.5 23 220 0.040±0.040 0.030±0.030 0.520±0.280 0.250±0.240 13 0.75 0.48 
 181 Putative pyridine nucleotide-disulphide 
oxidoreductase (S) 
6.13 48.7 49 285 0.430±0.040 0.460±0.060 0.200±0.040 0.240±0.020 0.47 1.07 1.20 
 136 Putative pyridine nucleotide-disulphide 
oxidoreductase (S) 
6.12 48.7 53 360 0.060±0.060 0.090±0.010 0.210±0.050 0.130±0.010 3.5 1.50 0.62 
 411 Guanylate kinase (S) 5.62 22.9 21 194 0.069±0.050 - 0.013±0.013 - 0.19 na na 
Stress 56 ATP-binding subunit of Clp protease and 
DnaK/DnaJ chaperones (S) 
5.53 76.9 23 274 0.064±0.020 0.081±0.004 0.008±0.008 0.010±0.010 0.13 1.26 1.25 
 228 ATP-dependent protease Clp, ATPase subunit (S) 5.03 46.5 32 149 0.043±0.043 0.071±0.069 0.160±0.040 0.190±0.040 3.72 1.65 1.19 
 427 Protease subunit of ATP-dependent Clp protease 
(A, S) 
4.96 21.3 36 153 0.160±0.020 0.860±0.020 0.300±0.020 0.870±0.080 1.88 5.38 2.90 
 190 Heat shock induced protein HtpO (A, S) 5.65 43.7 11 131 0.160±0.060 0.900±0.030 0.050±0.050 0.630±0.050 0.31 5.63 12.6 
 478 10 kDa chaperonin GroES (A) 4.84 10.3 54 111 0.360±0.040 0.800±0.040 0.270±0.020 1.020±0.100 0.75 2.22 3.78 
Translation 390 Transcription elongation factor (S) 4.64 18.0 51 168 0.110±0.040 0.240±0.006 0.210±0.040 0.280±0.030 1.91 2.18 1.33 
 429 Ribosome recycling factor 6.03 20.7 12 147 0.061±0.003 0.022±0.022 - - na 0.36 na 
 365 Putative dipeptidyl-peptidase 5.21 32.2 31 134 0.038±0.019 0.081±0.050 - - na 2.13 na 
 215 Elongation factor Tu (A) 4.85 43.3 47 191 0.910±0.090 0.360±0.180 1.270±0.550 0.640±0.550 1.40 0.40 0.50 
 117 Asparagine-tRNA ligase (A) 5.03 50.2 26 212 0.075±0.050 0.350±0.100 0.100±0.100 0.280±0.004 1.33 4.67 2.80 
 130 Glutamyl-tRNA synthetase 5.49 57.1 25 245 0.120±0.040 0.042±0.042 0.100±0.010 0.067±0.010 0.83 0.35 0.67 
 175 Seryl-tRNA synthetase (S) 5.11 49.4 55 472 0.080±0.080 0.070±0.070 0.280±0.280 0.280±0.100 3.50 0.80 1.00 
 68 Threonyl-tRNA synthetase (S) 5.05 72.9 23 221 0.380±0.130 - 0.050±0.050 - 0.13 na na 
 2 
 
 
 
a
 COG: functional category according to the Cluster of Orthologous Genes. 
b
 Spots numbers refer to the proteins excised from gels and reported in Figure 2. 
c
 Putative functions were assigned from the Kyoto Encyclopedia of Gene and Genomes (KEGG) pathways (www.genome.jp/kegg).  
d
 Theoretical isoelectric point expressed in pH. 
e
 Theoretical molecular masses expressed in kDa. 
f
 Percentage of sequence coverage. 
g
 Molecular weight search score. 
h
, Normalized relative volumes (percent volumes) for matching spots of parental and derivative strains. Only statistically significant results are presented. Values are means ± standard deviations: n ≥ 3 for each strain, -  not 
detected.  
i,
 Variation factor: ratio between normalized volumes for each protein derived from cells of L. delbrueckii subsp. lactis 200 and its bile-resistant derivative (200+) cultured in MRS broth without bile salts. 
j,k,
 Variation factor: ratio between normalized volumes for each protein derived from cells of L. delbrueckii subsp. lactis 200 (j) or its bile-resistant derivative (200+) (k) cultured in MRS broth with 0.2% wt/vol bile salts (b) 
and the corresponding strain grown without bile salts. 
n.a.: not applicable, due to the absence of detectable amount of protein for one of the conditions used for calculation of VF.  
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Table 2. Glucose consumption and organic acids formation in buffered suspension of resting cells 
obtained from cultures of Lactobacillus delbrueckii subsp. lactis 200 and its bile-resistant derivative 
200+ grown in MRS until mid-exponential phase (OD600 about 1.2). *** P < 0.001. 
 
 
 Mean ± SD (mM) 
Strain Glucose 
consumed 
Lactic acid Acetic acid Lactic/Acetic 
200 
200+ 
2.72±0.52 
6.30±0.33 
*** 
4.14±0.45 
10.01±0.24 
*** 
0.80±0.00 
0.41±0.02 
*** 
5.15±0.57 
24.70±0.62 
*** 
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